Tao Sun
18PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Feb 06, 2026
Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial.Pin Zhang, Tao Sun, Ying Wang
|Feb 01, 2026
The safety of trastuzumab deruxtecan (T-DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta-analysis.Yiwen Ma, Xiaorui Li, Yujun Jiang
|Dec 01, 2025
From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management.Junnan Xu, Kun Fang, Xiaoxi Li
|May 09, 2025
Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort.Xichun Hu, Qingyuan Zhang, Tao Sun
Pageof 3